Gabriel Holding A/S
11.2.2021 10:44:36 CET | Globenewswire | Press release
Summary:
Gabriel Holding A/S delivers solid revenue and earnings in the first quarter of the financial year.
Expectations for the full financial year are maintained.
- As expected, the current pandemic continued to challenge the conditions for growth
- The Group’s revenue was DKK 186.6 million (DKK 204.4 million), a decrease of 9%
- Earnings before depreciation, amortisation and impairment losses (EBITDA) decreased by 5% to DKK 24.7 million (DKK 26.0 million)
- Operating profit (EBIT) decreased by 13% to DKK 14.9 million (DKK 17.1 million)
- Profit before tax decreased by 21% to DKK 12.3 million (DKK 15.6 million)
- Return on invested capital was 14.7% (20.2%)
- Operating margin was 8.0% (8.4%)
Expectations for the 2020/21 financial year:
In the 2019/20 annual report, management predicted that the development in the Group’s revenue and earnings in the first half-year of 2020/21 would show a negative trend followed by a positive development in the second half of the year.
The realised revenue and earnings before tax are in line with management’s expectations for the first quarter of the financial year. The expectations for the full financial year are maintained unchanged at revenue of the order of DKK 760-790 million and profit before tax of the order of DKK 50-55 million.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Zealand Pharma19.4.2026 22:05:00 CEST | Press release
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Zealand Pharma19.4.2026 22:00:00 CEST | Press release
Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026
Schneider Electric19.4.2026 09:00:00 CEST | Press release
Challenge accepted: Schneider Electric helps industry turn toughest problems into competitive advantage
Chery Group18.4.2026 15:54:00 CEST | Press release
iCAUR V27 Secures CATARC L3 Off-Road Certification, Solidifying Its New Energy Off-Road Capability with Robust Technology
Sanofi Winthrop Industrie18.4.2026 12:00:00 CEST | Press release
Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
